Research graph
References from Urinary ER Chaperones – Biomarkers of Glomerular ER Stress. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrneph.2014.67
10.1038/nrneph.2014.67 · External reference
10.1038/nrneph.2017.129
10.1038/nrneph.2017.129 · External reference
The IRE1alpha pathway in glomerular diseases: The unfolded protein response and beyond
10.3389/fmmed.2022.971247 · 2022 · External reference
Research progress on endoplasmic reticulum homeostasis in kidney diseases
10.1038/s41419-023-05905-x · 2023 · External reference
Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease
10.1038/s41581-025-00938-1 · 2025 · External reference
Role of protein misfolding in human kidney diseases
2026 · External reference
10.1038/nrneph.2015.3
10.1038/nrneph.2015.3 · External reference
10.1038/nature17041
10.1038/nature17041 · External reference
10.1146/annurev-physiol-020911-153238
10.1146/annurev-physiol-020911-153238 · External reference
10.1056/nejmra1808786
10.1056/nejmra1808786 · External reference
10.3390/ijms22042161
10.3390/ijms22042161 · External reference
10.1146/annurev-biochem-072711-163904
10.1146/annurev-biochem-072711-163904 · External reference
10.15252/embj.201488896
10.15252/embj.201488896 · External reference
10.1385/jmn:20:2:173
10.1385/jmn:20:2:173 · External reference
10.1016/j.yjmcc.2010.10.008
10.1016/j.yjmcc.2010.10.008 · External reference
10.1038/s41374-020-0416-5
10.1038/s41374-020-0416-5 · External reference
Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology
10.1007/s00467-018-4031-2 · 2019 · External reference
Membranous nephropathy
10.1038/s41572-021-00303-z · 2021 · External reference
Novel treatments paradigms: membranous nephropathy
10.1016/j.ekir.2022.12.011 · 2023 · External reference
Therapeutic targets in membranous nephropathy: plasma cells and complement
10.1093/ckj/sfae243 · 2024 · External reference
10.2215/cjn.05960616
10.2215/cjn.05960616 · External reference
Novel treatment paradigms: focal segmental glomerulosclerosis
10.1016/j.ekir.2022.10.004 · 2023 · External reference
10.1074/jbc.m500729200
10.1074/jbc.m500729200 · External reference
Role of IRE1alpha in podocyte proteostasis and mitochondrial health
10.1038/s41420-020-00361-4 · 2020 · External reference
10.1038/ki.2012.390
10.1038/ki.2012.390 · External reference
10.1002/path.2446
10.1002/path.2446 · External reference
10.2353/ajpath.2006.040774
10.2353/ajpath.2006.040774 · External reference
10.1159/000446293
10.1159/000446293 · External reference
Analysis of gene expression and use of connectivity mapping to identify drugs for treatment of human glomerulopathies
2023 · External reference
10.1681/asn.2014100986
10.1681/asn.2014100986 · External reference
10.1172/jci.insight.92896
10.1172/jci.insight.92896 · External reference
10.1681/asn.2016020218
10.1681/asn.2016020218 · External reference
10.1053/j.ajkd.2018.07.020
10.1053/j.ajkd.2018.07.020 · External reference
10.1101/gr.155697.113
10.1101/gr.155697.113 · External reference
Vasculitis Clinical Research Consortium, the European Renal cDNA Bank cohort, and the Nephrotic Syndrome Study Network: Metabolic pathways and immunometabolism in rare kidney diseases
10.1136/annrheumdis-2017-212935 · 2018 · External reference
Deletion of IRE1alpha in podocytes exacerbates diabetic nephropathy in mice
10.1038/s41598-024-62599-7 · 2024 · External reference
10.1247/csf.07001
10.1247/csf.07001 · External reference
10.1016/j.yexcr.2008.05.001
10.1016/j.yexcr.2008.05.001 · External reference
10.4161/pri.28938
10.4161/pri.28938 · External reference
How to cure autoimmune GN and podocytopathies
10.1681/asn.0000000912 · 2026 · External reference
10.1093/ndt/gfp553
10.1093/ndt/gfp553 · External reference
10.1128/mcb.00417-13
10.1128/mcb.00417-13 · External reference
10.1242/jcs.125088
10.1242/jcs.125088 · External reference
10.1073/pnas.1813580116
10.1073/pnas.1813580116 · External reference
10.1074/jbc.rev120.010218
10.1074/jbc.rev120.010218 · External reference
